title: Combination of linagliptin and metformin for the treatment of patients with type 2 diabetes.
abstract: Type 2 diabetes mellitus (T2DM) is a progressive condition requiring long-term treatment. Most patients with T2DM are unable to maintain normoglycemia using metformin alone; thus, combination therapy is a pivotal part of disease management. Addition of the dipeptidyl peptidase-4 inhibitor linagliptin, with its proven efficacy, low propensity for hypoglycemia, and weight neutrality, has been shown to improve glycemic control for patients who are not well controlled with metformin. As patients often have other comorbidities requiring pharmacotherapy, an increase in pill number, different prescribing frequencies, and timing of medications may adversely impact patients' adherence. Studies have shown that treatment nonadherence contributes to increased morbidity, mortality, and healthcare cost. In the United States, the single-pill combination (SPC) of linagliptin/metformin is available in three strengths approved for twice-daily administration: 2.5/500 mg, 2.5/850 mg, and 2.5/1000 mg. The SPC has the potential to reduce pill burden and simplify patients' treatment regimens, thereby promoting improved adherence and efficacy.
authors: Diabetes Klinik Bad Mergentheim GmbH & Co. KG, Bad Mergentheim, Germany.
authors: Thomas
authors: T
authors: Haak
keywords: combination therapy; dipeptidyl peptidase-4 inhibitor; metformin; single-pill combination
references: Curr Med Res Opin. 2011 Jun;27(6):1157-68
references: 21466277
references: Lancet. 2012 Aug 4;380(9840):475-83
references: 22748821
references: J Endocrinol. 2012 Sep;214(3):381-7
references: 22761275
references: Diabetes Obes Metab. 2015 Feb;17(2):136-44
references: 25298165
references: J Clin Endocrinol Metab. 2003 Aug;88(8):3598-604
references: 12915642
references: Diabetes Obes Metab. 2012 Jun;14(6):565-74
references: 22356132
references: Diabetes Nutr Metab. 2004 Dec;17(6):336-42
references: 15887627
references: Public Health. 2014 Jan;128(1):70-6
references: 23969148
references: Diab Vasc Dis Res. 2013 Jul;10(4):289-301
references: 23449634
references: Diabetes Care. 2012 Jun;35(6):1364-79
references: 22517736
references: Diabetes. 2009 Apr;58(4):773-95
references: 19336687
references: Curr Med Res Opin. 2012 Jun;28(6):969-77
references: 22494018
references: Arch Intern Med. 2006 Sep 25;166(17):1836-41
references: 17000939
references: Diabet Med. 2011 Nov;28(11):1352-61
references: 21781152
references: J Med Econ. 2010 Mar;13(1):8-15
references: 19947905
references: Diabetes Care. 2001 Mar;24(3):489-94
references: 11289473
references: Drug Res (Stuttg). 2014 May;64(5):269-75
references: 24154935
references: Diabetes Obes Metab. 2012 Feb;14(2):101-11
references: 21752172
references: Diabet Med. 2012 Aug;29(8):e205-10
references: 22486277
references: Int J Clin Pract. 2013 Dec;67(12):1283-93
references: 24118640
references: Expert Opin Pharmacother. 2012 Jan;13(1):101-10
references: 22149370
references: Diabet Med. 2010 Dec;27(12):1409-19
references: 21059094
references: Clin Ther. 2010 Jul;32(7):1308-19
references: 20678679
references: Curr Med Res Opin. 2012 Sep;28(9):1465-74
references: 22816729
references: Diabetes Care. 2011 Jun;34(6):1431-7
references: 21617112
references: Clin Ther. 2002 Mar;24(3):460-7
references: 11952029
references: Endocr Pract. 2013 Mar-Apr;19(2):327-36
references: 23598536
references: Curr Med Res Opin. 2009 Aug;25(8):1963-72
references: 19552619
references: Adv Ther. 2012 Jan;29(1):1-13
references: 22271157
references: Int J Clin Pharmacol Ther. 2014 Jul;52(7):549-63
references: 24755124
references: Int J Clin Pharmacol Ther. 2014 Jul;52(7):537-48
references: 24755123
references: Clin Ther. 2008 Oct;30(10):1893-907
references: 19014846
references: Adv Ther. 2012 Jan;29(1):26-40
references: 22246944
references: Diabetes Obes Metab. 2011 Jan;13(1):65-74
references: 21114605
references: Diabetes Obes Metab. 2003 Nov;5(6):424-31
references: 14617228
references: Diabet Med. 2009 Apr;26(4):416-24
references: 19388973
references: Expert Opin Drug Metab Toxicol. 2013 Mar;9(3):363-77
references: 23373842
references: Diabetes Metab. 2003 Sep;29(4 Pt 2):6S28-35
references: 14502098
references: Diabet Med. 2014 Dec;31(12):1505-14
references: 24824197